LOPRIORE VINCENT S (Executive Chairman) purchased 6.25M shares of HEPION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $250.0K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 4/27/2026ACC: 0001493152-26-019029
DirectorOfficer· Executive Chairman
Since Mar 2026
+6.25M
Net shares
Net buyer
$250.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
6.25M acquired
Non-Derivative Transactions2
Common Stock, par value $0.0001 per share
Indirect
Shares
+5M
Price / share
$0.04
Trade value
$200K
% of position
New position
4/21/2026
0.00→5M
Common Stock, par value $0.0001 per share
Indirect
Shares
+1.25M
Price / share
$0.04
Trade value
$50K
% of position
25.0%
4/21/2026
5M→6.25M
Total
Net shares
+6.25M
Net value
$250K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Indirect | 4/21/2026 | P · Purchase | +5M | $0.04 | $200K | New position | 0.00 | 5M |
| Common Stock, par value $0.0001 per share Indirect | 4/21/2026 | P · Purchase | +1.25M | $0.04 | $50K | 25.0% | 5M | 6.25M |
| Total | +6.25M | $250K | ||||||
Derivative Transactions0
No derivative transactions reported